Global Contraceptives Market Driven by Increased Usage of Intrauterine Devices

The advent of oral contraceptive drugs, which are highly effective along with reduced side effects, has opened new frontiers for the global contraceptives market. According to a recent business publication by IndustryARC, the global contraceptives market size was around $20 billion to $21 billion in 2018 and anticipated to flourish at a CAGR ranging from 6% to 7% over the forecast period 2019-2025. Rising awareness towards sexually transmitted infections and government ardent efforts to promote the use of contraceptives, which helps to reduce the rate of unintended pregnancies are increasing demand for contraceptives worldwide. The rapid growth in the consumer base of contraceptives is mainly due to the increasingly unstable relationships cases. It is also used to postpone the motherhood, and to prioritize the careers of individuals. The report titled “Contraceptives Market: By Product (Drug, Devices); By End-User (Hospital, Clinic, Home Care, Ambulatory Surgical Centre) & By region – Forecast (2019 - 2025),”includes a meticulous analysis of growth factors, drivers, leading segments and key trends of the global contraceptives market.

As per the findings of Centres for Disease Control and Prevention, around 38,739 people in the U.S. were affected by HIV in 2017. The increasing prevalence of various sexually transmitted diseases such as HIV, genital herpes and trichomoniasis are proliferating the growth of contraceptives market in North America. Hence, this region accounted for a massive share in the global contraceptives market, which is around 28% to 30% in 2018.

Intrauterine devices (IUT) are the prominent product type, which is projected to grow at CAGR of around 30% to 35% during the aforementioned forecast period. Widespread adoption of these devices is mainly because it is more effective as compared to other devices. It prevents pregnancy and lasts for around five to ten years. The usage of IUT does not affect the weight of the person, which is the notable advantage of these devices.

Some of the key companies identified in the report that are currently holding majority shares in the global contraceptives market are Cooper Surgical, Inc., Pfizer, Inc., Actavis, Inc.Teva Pharmaceutical Industries Limited, Bayer AG), The Female Health Company, Merck & Co., Inc., Mayer Laboratories, Inc., Church & Dwight, Co., Inc., and Medisafe Distribution Inc.

Hormonal Contraception Market: By Hormone (Androgens, Estrogens, Progestrogens, Gonadotropins, Antiandrogens); By Method (Combined Oral, Oral Pill, Implanted, Injected, Others); By End-User (Hospital, Clinics, Others) and By Region-Forecast (2018-2023)

Contraceptive Drugs And Devices Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024